Ipswich Investment Management Co. Inc. Sells 960 Shares of Colgate-Palmolive (NYSE:CL)

Ipswich Investment Management Co. Inc. reduced its position in Colgate-Palmolive (NYSE:CL) by 7.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 11,902 shares of the company’s stock after selling 960 shares during the period. Ipswich Investment Management Co. Inc.’s holdings in Colgate-Palmolive were worth $1,082,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. AR Asset Management Inc. acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $1,636,000. Drum Hill Capital LLC acquired a new stake in Colgate-Palmolive during the 4th quarter valued at $302,000. Capital Advisory Group Advisory Services LLC boosted its position in Colgate-Palmolive by 3.6% during the fourth quarter. Capital Advisory Group Advisory Services LLC now owns 3,830 shares of the company’s stock worth $348,000 after purchasing an additional 132 shares during the period. Cordatus Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 1.1% in the fourth quarter. Cordatus Wealth Management LLC now owns 22,915 shares of the company’s stock valued at $2,083,000 after purchasing an additional 251 shares during the last quarter. Finally, Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $27,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.9 %

Shares of Colgate-Palmolive stock opened at $89.56 on Friday. The firm has a market capitalization of $72.68 billion, a PE ratio of 25.44, a price-to-earnings-growth ratio of 4.18 and a beta of 0.44. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. The firm’s 50 day moving average is $88.94 and its 200 day moving average is $95.91. Colgate-Palmolive has a 1 year low of $84.45 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the company posted $0.87 EPS. Equities research analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were issued a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.23%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.

Wall Street Analyst Weigh In

A number of research analysts recently commented on CL shares. Piper Sandler decreased their price target on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a research note on Monday, January 6th. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. UBS Group dropped their price target on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. Royal Bank of Canada reiterated a “sector perform” rating and set a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Finally, Raymond James reissued an “outperform” rating and issued a $105.00 target price (down previously from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $101.16.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.